Advanced

AJNR - American Journal of Neuroradiology

Published ahead of print on March 27, 2008
doi: 10.3174/ajnr.A1005

This Article Figures Only Full Text Full Text (PDF) All Versions of this Article: ajnr.A1005v1 29/6/1053    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via CrossRef Google Scholar Articles by Hänggi, D. Articles by Steiger, H.J. PubMed PubMed Citation Articles by Hänggi, D. Articles by Steiger, H.J.

American Journal of Neuroradiology 29:1053-1060, June-July 2008
© 2008 American Society of Neuroradiology

INTERVENTIONAL

Intra-Arterial Nimodipine for Severe Cerebral Vasospasm after Aneurysmal Subarachnoid Hemorrhage: Influence on Clinical Course and Cerebral Perfusion

D. Hänggi^a, B. Turowski^b, K. Beseoglu^a, M. Yong^c and H.J. Steiger^a

^a Departments of Neurosurgery, Heinrich-Heine-University, Düsseldorf, Germany
^b Neuroradiology, Heinrich-Heine-University, Düsseldorf, Germany
^c Institute of Statistics in Medicine, Heinrich-Heine-University, Düsseldorf, Germany

Please address correspondence to Daniel Hänggi, MD, Department of Neurosurgery, Heinrich-Heine-University, Moorenstraβe 5, Geb. 13.71, 40225-Düsseldorf, Germany; e-mail: Daniel.Haenggi{at}uni-duesseldorf.de

BACKGROUND AND PURPOSE: The efficacy of intra-arterial administration of nimodipine (IAN) in patients with severe vasospasm after aneurysmal subarachnoid hemorrhage (SAH) remains unproved. The goal of the present study was to investigate the clinical effect and cerebral perfusion after IAN in patients with severe vasospasm refractory to hemodynamic treatment.

MATERIALS AND METHODS: Twenty-six of 214 patients with aneurysmal SAH were included in the prospective study, approved by the local ethics committee. All patients met the criteria of medically refractory cerebral vasospasm. Effectiveness was monitored angiographically by digital subtraction angiography and by transcranial Doppler (TCD), perfusion CT (PCT), and neurologic examination during treatment course and follow-up.

RESULTS: No angiographic effect was observed in 8 patients. The pooled PCT values revealed a reduction of time to peak (P = .03) and mean transit time (P = .17) 1 day after intervention. This effect did not persist during the following days. The pooled TCD analysis demonstrated a transient increase in flow 1 day after intervention (P = .03). No trend was evident during the next 7 days after intervention. Additional infarction was experienced by 61.1% of patients.

CONCLUSIONS: IAN in a selective patient group resulted in a positive response with reduction of angiographic vasospasm and increase in cerebral perfusion as detected by PCT after 24 hours. Therefore, IAN appears more effective than intra-arterial papaverine. Nevertheless the efficacy of IAN is temporary. Therefore, the search for more effective treatment strategies to reduce critical vasospasm and to improve cerebral perfusion must be continued.